EP2362909A4 - Mammalian genes involved in infection - Google Patents
Mammalian genes involved in infectionInfo
- Publication number
- EP2362909A4 EP2362909A4 EP09818408A EP09818408A EP2362909A4 EP 2362909 A4 EP2362909 A4 EP 2362909A4 EP 09818408 A EP09818408 A EP 09818408A EP 09818408 A EP09818408 A EP 09818408A EP 2362909 A4 EP2362909 A4 EP 2362909A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- infection
- genes involved
- mammalian genes
- mammalian
- involved
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y601/00—Ligases forming carbon-oxygen bonds (6.1)
- C12Y601/01—Ligases forming aminoacyl-tRNA and related compounds (6.1.1)
- C12Y601/01005—Isoleucine-tRNA ligase (6.1.1.5)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2330/00—Production
- C12N2330/30—Production chemically synthesised
- C12N2330/31—Libraries, arrays
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- Plant Pathology (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Physics & Mathematics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19477408P | 2008-09-30 | 2008-09-30 | |
US19577008P | 2008-10-09 | 2008-10-09 | |
PCT/US2009/058947 WO2010039778A2 (en) | 2008-09-30 | 2009-09-30 | Mammalian genes involved in infection |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2362909A2 EP2362909A2 (en) | 2011-09-07 |
EP2362909A4 true EP2362909A4 (en) | 2012-10-10 |
Family
ID=42074170
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP09818408A Withdrawn EP2362909A4 (en) | 2008-09-30 | 2009-09-30 | Mammalian genes involved in infection |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2362909A4 (en) |
WO (1) | WO2010039778A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012058268A2 (en) * | 2010-10-27 | 2012-05-03 | Opko Curna Llc | Treatment of interferon-related developmental regulator 1 (ifrd1) related diseases by inhibition of natural antisense transcript to ifrd1 |
JP6249447B2 (en) | 2012-01-24 | 2017-12-20 | インターケー・ペプチド・セラピューティクス・リミテッド | Peptide agent for cancer treatment |
FR2987627B1 (en) * | 2012-03-05 | 2016-03-18 | Splicos | USE OF RBM39 AS A BIOMARKER |
CA2877948C (en) | 2012-07-02 | 2019-07-30 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Paramyxovirus and methods of use |
US9732345B2 (en) * | 2013-12-09 | 2017-08-15 | Baylor College Of Medicine | Hippo and dystrophin complex signaling in cardiomyocyte renewal |
WO2019119036A1 (en) * | 2017-12-19 | 2019-06-27 | Benitec Biopharma Limited | Cd70 deficient cells, and methods and reagents for producing same |
CN108707607A (en) * | 2018-06-08 | 2018-10-26 | 邵玉芹 | A kind of aptamers and kit of energy specific detection EV71 viruses |
CN113274510B (en) * | 2021-04-29 | 2022-05-13 | 山东农业大学 | Composition for inhibiting J subgroup avian leukosis virus replication and application thereof |
WO2024119145A1 (en) * | 2022-12-01 | 2024-06-06 | Camp4 Therapeutics Corporation | Modulation of syngap1 gene transcription using antisense oligonucleotides targeting regulatory rnas |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040018505A1 (en) * | 2001-06-29 | 2004-01-29 | Lee Ernestine A. | Aminoacyl trna synthetases |
US20060079474A1 (en) * | 2004-10-07 | 2006-04-13 | Paul Glidden | Analogs of tRNA synthetase fragments and uses thereof |
US8247451B2 (en) * | 2006-01-13 | 2012-08-21 | Vanderbilt University | ADAM10 and its uses related to infection |
-
2009
- 2009-09-30 EP EP09818408A patent/EP2362909A4/en not_active Withdrawn
- 2009-09-30 WO PCT/US2009/058947 patent/WO2010039778A2/en active Application Filing
Non-Patent Citations (4)
Title |
---|
CLAYTON F ET AL: "Gp120-induced Bob/GPR15 activation: a possible cause of human immunodeficiency virus enteropathy.", THE AMERICAN JOURNAL OF PATHOLOGY, vol. 159, no. 5, November 2001 (2001-11-01), pages 1933 - 1939, XP002682331, ISSN: 0002-9440 * |
D. MCDONALD: "Visualization of the intracellular behavior of HIV in living cells", THE JOURNAL OF CELL BIOLOGY, vol. 159, no. 3, 11 November 2002 (2002-11-11), pages 441 - 452, XP055036240, ISSN: 0021-9525, DOI: 10.1083/jcb.200203150 * |
KENNEY SHANNON: "Theodore E. Woodward Award: development of novel, EBV-targeted therapies for EBV-positive tumors.", TRANSACTIONS OF THE AMERICAN CLINICAL AND CLIMATOLOGICAL ASSOCIATION, vol. 117, 2006, pages 55 - 74, XP002682332, ISSN: 0065-7778 * |
W. ZHANG ET AL: "RNA Interference Inhibits Respiratory Syncytial Virus Replication and Disease Pathogenesis without Inhibiting Priming of the Memory Immune Response", JOURNAL OF VIROLOGY, vol. 82, no. 24, 25 September 2008 (2008-09-25), pages 12221 - 12231, XP055036354, ISSN: 0022-538X, DOI: 10.1128/JVI.01557-08 * |
Also Published As
Publication number | Publication date |
---|---|
WO2010039778A3 (en) | 2010-09-16 |
WO2010039778A2 (en) | 2010-04-08 |
EP2362909A2 (en) | 2011-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG25742A (en) | Photobioreactor | |
ZA201008391B (en) | Pluripotent cells | |
AP2015008431A0 (en) | Improvements in feedwells | |
ZA201100093B (en) | Novel genes involved in biosynthesis | |
GB0820262D0 (en) | Microorganisms | |
EP2362909A4 (en) | Mammalian genes involved in infection | |
EP2180037A4 (en) | Culture system | |
GB0800702D0 (en) | Genes | |
GB0800524D0 (en) | Cell culture system | |
GB0814573D0 (en) | Photobioreactors | |
GB201012650D0 (en) | Bioreactor | |
GB0817240D0 (en) | Modified bacterial cell | |
EP2405001A4 (en) | Nucleic acid complex and nucleic acid-delivering composition | |
GB0823515D0 (en) | Improvements in bivvies | |
GB0806645D0 (en) | Culture | |
GB0806636D0 (en) | Culture | |
GB0806640D0 (en) | Culture | |
GB0806639D0 (en) | Culture | |
GB0806637D0 (en) | Culture | |
GB0806642D0 (en) | Culture | |
GB0806643D0 (en) | Culture | |
GB0806644D0 (en) | Culture | |
GB0806638D0 (en) | Culture | |
GB0806646D0 (en) | Culture | |
GB0806641D0 (en) | Culture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20110502 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 48/00 20060101ALI20120828BHEP Ipc: A61K 31/00 20060101ALI20120828BHEP Ipc: C12N 15/113 20100101AFI20120828BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20120911 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 48/00 20060101ALI20120904BHEP Ipc: C12N 15/113 20100101AFI20120904BHEP Ipc: A61K 31/00 20060101ALI20120904BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20130403 |